|
ZNF468 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.698100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.548400E-02 |
| Normal-vs-Stage2 |
9.285600E-02 |
| Normal-vs-Stage3 |
1.569230E-01 |
| Normal-vs-Stage4 |
1.409550E-02 |
| Stage1-vs-Stage2 |
9.073000E-01 |
| Stage1-vs-Stage3 |
9.877000E-01 |
| Stage1-vs-Stage4 |
4.391200E-01 |
| Stage2-vs-Stage3 |
9.241800E-01 |
| Stage2-vs-Stage4 |
4.199400E-01 |
| Stage3-vs-Stage4 |
4.421800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.287900E-02 |
| Normal-vs-AfricanAmerican |
2.569500E-02 |
| Normal-vs-Asian |
7.177400E-01 |
| Caucasian-vs-AfricanAmerican |
5.549200E-01 |
| Caucasian-vs-Asian |
7.008000E-01 |
| AfricanAmerican-vs-Asian |
5.134000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.189870E-02 |
| Normal-vs-Female |
3.759600E-01 |
| Male-vs-Female |
1.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.727600E-01 |
| Normal-vs-Extreme_Weight |
6.600600E-03 |
| Normal-vs-Obese |
1.558420E-01 |
| Normal-vs-Extreme_Obese |
6.655900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.918400E-01 |
| Normal_Weight-vs-Obese |
9.825000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.610200E-01 |
| Extreme_Weight-vs-Obese |
1.634450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.484600E-01 |
| Obese-vs-Extreme_Obese |
4.903200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.010000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.454360E-01 |
| Normal-vs-Age(61-80Yrs) |
2.101500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.403400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.993350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.660000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.917200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.605600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.225600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.107800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.098400E-02 |
| Normal-VS-Type2 PRCC |
1.818780E-01 |
| Normal-VS-KIRP CIMP |
6.740600E-03 |
| Normal-VS-Unclassified PRCC |
4.973800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.594000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.068200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.653400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.357750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.291200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.306600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.285000E-03 |
| Normal-vs-N1 |
2.569400E-01 |
| Normal-vs-N2 |
8.222600E-04 |
| N0-vs-N1 |
2.668200E-01 |
| N0-vs-N2 |
5.646100E-02 |
| N1-vs-N2 |
1.191770E-04 |
|
|
